The road map toward an hepatitis C virus-free transplant population.

Berenguer, M; Agarwal, K; Burra, P; Manns, M; Samuel, D

Berenguer, M; Agarwal, K; Burra, P; Manns, M; Samuel, D.

Affiliation

Berenguer M; Liver Transplantation & Hepatology Unit, Hospital Universitario La Fe, University of Valencia-CIBEReHD, Valencia, Spain.
Agarwal K; Institute of Liver Studies, King's College Hospital, London, UK.
Burra P; Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.
Manns M; Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
Samuel D; Inserm-Paris Sud Unit 1193, Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif, France.

Am J Transplant ; 18(10): 2409-2416, 2018 10.

Article in En | MEDLINE | ID: mdl-29935050

Subject(s)

Antiviral Agents/therapeutic use; Hepacivirus/drug effects; Hepatitis C/drug therapy; Liver Transplantation; Postoperative Complications/prevention & control; Hepatitis C/virology; Humans

Key words

clinical research/practice; editorial/personal viewpoint; infection and infectious agents-viral: hepatitis C; infectious disease; liver disease: infectious; liver transplantation/hepatology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Postoperative Complications / Liver Transplantation / Hepatitis C / Hepacivirus Limits: Humans Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2018 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google